Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	N-Acetylcysteine	111
Overall Study	STARTED	Ambroxol Hydrochloride	111
Overall Study	STARTED	Placebo	111
Overall Study	Modified ITT	N-Acetylcysteine	108
Overall Study	Modified ITT	Ambroxol Hydrochloride	110
Overall Study	Modified ITT	Placebo	110
Overall Study	COMPLETED	N-Acetylcysteine	96
Overall Study	COMPLETED	Ambroxol Hydrochloride	95
Overall Study	COMPLETED	Placebo	97
Overall Study	NOT COMPLETED	N-Acetylcysteine	15
Overall Study	NOT COMPLETED	Ambroxol Hydrochloride	16
Overall Study	NOT COMPLETED	Placebo	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03843541/flow